(Q85077978)
Statements
Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after imatinib resistance is predictive of outcome during subsequent therapy (English)
Wendy T Parker
Rebecca M Lawrence
Musei Ho
Darryl L Irwin
Timothy P Hughes
Susan Branford
11 October 2011